Mi az ára Fresenius SE & Co. KGaA (FSNUY)

Fresenius SE & Co. KGaA (FSNUY) ára $12.65

Mi a Fresenius SE & Co. KGaA (FSNUY piaci tőkésítése)

Fresenius SE & Co. KGaA piaci tőkésítése (FSNUY) $114.00B

Fresenius SE & Co. KGaA (FSNUY) Működési Eredményhányad

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Év	Működési árrés	Változtassa meg
2026 (TTM)	9.45%	15.81%
2024	8.16%	59.06%
2023	5.13%	-40.28%
2022	8.59%	-22.47%
2021	11.08%	-8.35%
2020	12.09%	-7.57%
2019	13.08%	-1.28%
2018	13.25%	-2.14%
2017	13.54%	-9.01%
2016	14.88%	6.06%
2015	14.03%	4.70%
2014	13.40%	-8.91%
2013	14.71%	-4.85%
2012	15.46%	-0.32%
2011	15.51%	2.44%
2010	15.14%	4.27%
2009	14.52%	21.30%
2008	11.97%	-68.59%
2007	38.11%	2.01%
2006	37.36%	-6.13%
2005	39.80%	6.05%
2004	37.53%	250.09%
2003	10.72%	-0.65%
2002	10.79%	0.00%

Év

Működési árrés

Változtassa meg

2026 (TTM)

9.45%

15.81%

2024

8.16%

59.06%

2023

5.13%

-40.28%

2022

8.59%

-22.47%

2021

11.08%

-8.35%

2020

12.09%

-7.57%

2019

13.08%

-1.28%

2018

13.25%

-2.14%

2017

13.54%

-9.01%

2016

14.88%

6.06%

2015

14.03%

4.70%

2014

13.40%

-8.91%

2013

14.71%

-4.85%

2012

15.46%

-0.32%

2011

15.51%

2.44%

2010

15.14%

4.27%

2009

14.52%

21.30%

2008

11.97%

-68.59%

2007

38.11%

2.01%

2006

37.36%

-6.13%

2005

39.80%

6.05%

2004

37.53%

250.09%

2003

10.72%

-0.65%

2002

10.79%

0.00%

Vállalat	Működési árrés	Működési árrés különbség	Ország
HCA Healthcare, Inc. HCA.US	15.67%	-98.34%	US
Dr. Sulaiman Al Habib Medical Services Group Company 4013.SR	18.60%	-98.03%	SA
Tenet Healthcare Corporation THC.US	16.14%	-98.29%	US
JD Health International Inc. 6618.HK	5.17%	-99.45%	CN
DaVita Inc. DVA.US	15.01%	-98.41%	US

Vállalat

Működési árrés

Működési árrés különbség

Ország